Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Everett WA, Edmonds WA, Seattle WA, Mount Vernon WA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Location: Everett WA, Edmonds WA, Seattle WA, Mount Vernon WA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase2, Recruiting

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Mill Creek WA, Surrey, Warrenton OR, Portland OR,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07474792

Phase2, Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Mill Creek WA, Seattle WA, Oakland CA, Bountiful UT,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Mill Creek WA, Surrey, Nanaimo, Portland OR, Kelowna,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Mill Creek WA, Edmonton, Walnut Creek CA, Fremont CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase3, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: Mill Creek WA, Seattle WA, Vancouver, Spokane WA,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase3, Recruiting

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for
Lichen Planopilaris
Location: Mill Creek WA, Portland OR, Edmonton, Sacramento CA,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07532603

Phase2, Phase3, Recruiting

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

for
Peripheral Arterial Disease
Location: Lynnwood WA, Redmond WA, Redding CA, Clinton UT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07223593

Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Lynnwood WA, Surrey, Kelowna, Missoula MT, Boise ID,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase3, Recruiting

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

for
Sjögren's Syndrome
Location: Bothell WA, Covina CA, Fort Collins CO, Flagstaff AZ,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06747949

Phase3, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Edmonds WA, Seattle WA, Issaquah WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Edmonds WA, Seattle WA, Issaquah WA, Portland OR,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase2, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Edmonds WA, Seattle WA, Issaquah WA, Portland OR,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: Edmonds WA, Saint Paul MN, Iowa City IA, Dallas TX,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase1, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Edmonds WA, Seattle WA, Issaquah WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Edmonds WA, Seattle WA, Issaquah WA, Portland OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Location: Edmonds WA, San Francisco CA, Salt Lake City UT,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05727904

Phase3, Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: Edmonds WA, Seattle WA, Portland OR, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05256225

Phase3, Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

for
Metastatic Castration-Resistant Prostate Carcinoma,
Location: Edmonds WA, Seattle WA, Portland OR, Post Falls ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT07200830

Phase3, Recruiting